Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Asset Utilization Ratio: 2011-2018

Historic Asset Utilization Ratio for EyePoint Pharmaceuticals (EYPT) over the last 7 years, with Sep 2018 value amounting to 0.03.

  • EyePoint Pharmaceuticals' Asset Utilization Ratio fell 94.19% to 0.03 in Q3 2018 from the same period last year, while for Sep 2018 it was 0.03, marking a year-over-year decrease of 94.19%. This contributed to the annual value of 0.07 for FY2018, which is 78.14% down from last year.
  • EyePoint Pharmaceuticals' Asset Utilization Ratio amounted to 0.03 in Q3 2018, which was down 20.50% from 0.03 recorded in Q2 2018.
  • In the past 5 years, EyePoint Pharmaceuticals' Asset Utilization Ratio ranged from a high of 0.85 in Q3 2014 and a low of 0.03 during Q3 2018.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.07 (2018), whereas its average is 0.18.
  • In the last 5 years, EyePoint Pharmaceuticals' Asset Utilization Ratio skyrocketed by 844.27% in 2017 and then slumped by 94.19% in 2018.
  • Quarterly analysis of 5 years shows EyePoint Pharmaceuticals' Asset Utilization Ratio stood at 0.67 in 2014, then plummeted by 89.96% to 0.07 in 2015, then surged by 357.60% to 0.31 in 2016, then plummeted by 58.07% to 0.13 in 2017, then tumbled by 94.19% to 0.03 in 2018.
  • Its Asset Utilization Ratio was 0.03 in Q3 2018, compared to 0.03 in Q2 2018 and 0.07 in Q1 2018.